Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial.
BACKGROUND: The role and dose of anticoagulants in thromboprophylaxis for patients with cancer receiving chemotherapy through central venous catheters (CVCs) is controversial. We therefore assessed whether warfarin reduces catheter-related thrombosis compared with no warfarin and whether the dose of...
Main Authors: | Young, A, Billingham, L, Begum, G, Kerr, D, Hughes, A, Rea, D, Shepherd, S, Stanley, A, Sweeney, A, Wilde, J, Wheatley, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol
by: George Tomlinson, et al.
Published: (2024-01-01) -
Primary Thromboprophylaxis for the Prevention of Venous Thromboembolism in Cancer Patients with Central Venous Catheters: A Literature Review
by: Hikmat Abdel-Razeq, et al.
Published: (2024-03-01) -
The benefit of pharmacological venous thromboprophylaxis in foot and ankle surgery
by: N P Saragas, et al.
Published: (2017-04-01) -
Venous Thromboembolism and Primary Thromboprophylaxis in Perioperative Pancreatic Cancer Care
by: R. A. L. Willems, et al.
Published: (2023-07-01) -
Thromboprophylaxis for venous thromboembolism prevention in hip fracture patients
Published: (2017-03-01)